Hyperammonemia in patients receiving valproic acid in the hospital setting: A retrospective review

• Main Authors: Tressa McMorris, PharmD, BCPS (Author), Angela Chu, PharmD, BCPS (Author), Lynn Vu, PharmD (Author), Amanda Bernardini, PharmD (Author)
• Format: Book
• Published: American Association of Psychiatric Pharmacists, 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Valproic acid (VPA) is widely used for the treatment of epilepsy, migraine, and a variety of psychiatric conditions. The reported incidences of hyperammonemia induced by VPA use is variable. The purpose of this study is to evaluate the incidence of VPA-induced hyperammonemia in the gen...